T. Rowe Price Associates’s Immunocore IMCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$27.7M Sell
919,332
-49,452
-5% -$1.6M ﹤0.01% 952
2025
Q4
$33.6M Sell
968,784
-47,987
-5% -$1.69M ﹤0.01% 933
2025
Q3
$36.9M Buy
1,016,771
+11,179
+1% +$380K ﹤0.01% 883
2025
Q2
$31.6M Sell
1,005,592
-882,348
-47% -$27.4M ﹤0.01% 854
2025
Q1
$56M Sell
1,887,940
-299,590
-14% -$8.99M 0.01% 694
2024
Q4
$64.5M Buy
2,187,530
+29,832
+1% +$943K 0.01% 673
2024
Q3
$67.2M Sell
2,157,698
-674,971
-24% -$24.5M 0.01% 669
2024
Q2
$96M Buy
2,832,669
+395,085
+16% +$20.2M 0.01% 551
2024
Q1
$158M Sell
2,437,584
-506,990
-17% -$34.8M 0.02% 465
2023
Q4
$201M Buy
2,944,574
+423,290
+17% +$22M 0.03% 420
2023
Q3
$131M Buy
2,521,284
+97,864
+4% +$5.79M 0.02% 465
2023
Q2
$145M Buy
2,423,420
+1,039,980
+75% +$59.4M 0.02% 452
2023
Q1
$68.4M Buy
1,383,440
+49,524
+4% +$2.78M 0.01% 602
2022
Q4
$76.1M Buy
1,333,916
+170,355
+15% +$9.59M 0.01% 550
2022
Q3
$54.6M Buy
1,163,561
+849,662
+271% +$40.5M 0.01% 624
2022
Q2
$11.7M Sell
313,899
-29,380
-9% -$954K ﹤0.01% 1298
2022
Q1
$10.3M Sell
343,279
-36,612
-10% -$924K ﹤0.01% 1364
2021
Q4
$13M Buy
379,891
+17,865
+5% +$647K ﹤0.01% 1368
2021
Q3
$13.4M Sell
362,026
-5,278
-1% -$178K ﹤0.01% 1384
2021
Q2
$14.3M Sell
367,304
-20,608
-5% -$796K ﹤0.01% 1369
2021
Q1
$16.5M Buy
+387,912
New +$17.3M ﹤0.01% 1317

Other funds holding IMCR